BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34994102)

  • 1. Perfluorocarbon Nanoemulsions Enhance Therapeutic siRNA Delivery in the Treatment of Pulmonary Fibrosis.
    Ding L; Tang S; Tang W; Mosley DD; Yu A; Sil D; Romanova S; Bailey KL; Knoell DL; Wyatt TA; Oupický D
    Adv Sci (Weinh); 2022 Mar; 9(8):e2103676. PubMed ID: 34994102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
    Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
    Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.
    Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M
    Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.
    Liu Y; Zheng Y
    Int J Mol Med; 2017 Jan; 39(1):91-100. PubMed ID: 27959382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis.
    Lu YZ; He XL; Liu F; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Yu F; Xin JB; Ye H; Song LJ; Ma WL
    Exp Cell Res; 2020 Nov; 396(1):112295. PubMed ID: 32971116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis.
    Tomaru A; Kobayashi T; Hinneh JA; Baffour Tonto P; D'Alessandro-Gabazza CN; Fujimoto H; Fujiwara K; Takahashi Y; Ohnishi M; Yasuma T; Nishihama K; Yoshino M; Takao K; Toda M; Totoki T; Takei Y; Yoshikawa K; Taguchi O; Gabazza EC
    Gene Ther; 2017 Nov; 24(11):706-716. PubMed ID: 28820502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
    Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
    J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis.
    Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D
    Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis.
    Yoon PO; Park JW; Lee CM; Kim SH; Kim HN; Ko Y; Bae SJ; Yun S; Park JH; Kwon T; Kim WS; Lee J; Lu Q; Kang HR; Cho WK; Elias JA; Yang JS; Park HO; Lee K; Lee CG
    J Biol Chem; 2016 Mar; 291(12):6433-46. PubMed ID: 26817844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.
    Wang JC; Lai S; Guo X; Zhang X; de Crombrugghe B; Sonnylal S; Arnett FC; Zhou X
    Arthritis Res Ther; 2010; 12(2):R60. PubMed ID: 20359365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of siPTPN13 and siNOX4
    Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X
    Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085
    [No Abstract]   [Full Text] [Related]  

  • 13. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
    Kim S; Lim JH; Woo CH
    Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal prostaglandin E synthase-1 deficiency exacerbates pulmonary fibrosis induced by bleomycin in mice.
    Wei B; Cai L; Sun D; Wang Y; Wang C; Chai X; Xie F; Su M; Ding F; Liu J; Yang J; Guan Y; Liu X
    Molecules; 2014 Apr; 19(4):4967-85. PubMed ID: 24756129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer.
    Ding L; Tang S; Yu A; Wang A; Tang W; Jia H; Oupický D
    ACS Appl Mater Interfaces; 2022 Mar; 14(8):10015-10029. PubMed ID: 35188730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes.
    Otsuka M; Shiratori M; Chiba H; Kuronuma K; Sato Y; Niitsu Y; Takahashi H
    Exp Lung Res; 2017; 43(6-7):271-282. PubMed ID: 29035148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis.
    Pan T; Zhou Q; Miao K; Zhang L; Wu G; Yu J; Xu Y; Xiong W; Li Y; Wang Y
    Theranostics; 2021; 11(3):1192-1206. PubMed ID: 33391530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.
    Kim TH; Kim SH; Seo JY; Chung H; Kwak HJ; Lee SK; Yoon HJ; Shin DH; Park SS; Sohn JW
    Tohoku J Exp Med; 2011 Jan; 223(1):45-54. PubMed ID: 21212602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial 8-oxoguanine DNA glycosylase mitigates alveolar epithelial cell PINK1 deficiency, mitochondrial DNA damage, apoptosis, and lung fibrosis.
    Kim SJ; Cheresh P; Jablonski RP; Rachek L; Yeldandi A; Piseaux-Aillon R; Ciesielski MJ; Ridge K; Gottardi C; Lam AP; Pardo A; Selman M; Natarajan V; Kamp DW
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1084-L1096. PubMed ID: 32209025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.